(Q43807384)

27 November 2017

Effect of clozapine, haloperidol, or M100907 on phencyclidine-activated glutamate efflux in the prefrontal cortex (English)

1 reference

27 November 2017

1 reference

B W Adams

1

1 reference

PubMed ID

11720693

27 November 2017

B Moghaddam

series ordinal

2

1 reference

PubMed ID

11720693

27 November 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

27 November 2017

Biological Psychiatry

1 reference

27 November 2017

50

1 reference

27 November 2017

10

1 reference

27 November 2017

750-757

1 reference

Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine.

27 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901195-7

Effects of ketamine on thought disorder, working memory, and semantic memory in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901195-7

Serotonin, via 5-HT2A receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901195-7

Serotonin model of schizophrenia: emerging role of glutamate mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901195-7

Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901195-7

Phencyclidine (PCP): a review and perspectives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901195-7

Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901195-7

Behavioural and neurochemical interactions of the AMPA antagonist GYKI 52466 and the non-competitive NMDA antagonist dizocilpine in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901195-7

Perspectives: acute phencyclidine intoxication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901195-7

Rewarding actions of phencyclidine and related drugs in nucleus accumbens shell and frontal cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901195-7

Effects of dopaminergic drugs on phencyclidine-induced behavior in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901195-7

Effects of atypical antipsychotic agents on social behavior in rodents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901195-7

The glutamatergic dysfunction hypothesis for schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901195-7

Actions of clozapine and haloperidol on the extracellular levels of excitatory amino acids in the prefrontal cortex and striatum of conscious rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901195-7

Assessing prepulse inhibition of startle in wild-type and knockout mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901195-7

The effects of haloperidol and clozapine on the disruption of sensorimotor gating induced by the noncompetitive glutamate antagonist MK-801.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901195-7

Effect of phencyclidine on dopamine release in the rat prefrontal cortex; an in vivo microdialysis study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901195-7

Dopamine receptor antagonists block amphetamine and phencyclidine-induced motor stimulation in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901195-7

Recent advances in the phencyclidine model of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901195-7

Excitatory amino acid receptors mediate the orofacial stereotypy elicited by dopaminergic stimulation of the ventrolateral striatum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901195-7

Effects of risperidone on phencyclidine-induced behaviors: comparison with haloperidol and ritanserin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901195-7

Modulation of phencyclidine-induced changes in locomotor activity and patterns in rats by serotonin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901195-7

Therapeutic Implications of the Hyperglutamatergic Effects of NMDA Antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901195-7

Interactive effects of subanesthetic ketamine and haloperidol in healthy humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901195-7

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901195-7

Ketamine activates psychosis and alters limbic blood flow in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901195-7

Clozapine blunts N-methyl-D-aspartate antagonist-induced psychosis: a study with ketamine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901195-7

The electrophysiology of prefrontal serotonin systems: therapeutic implications for mood and psychosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901195-7

Systemic PCP treatment elevates brain extracellular 5-HT: a microdialysis study in awake rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901195-7

MK-801-induced hyperlocomotion: differential effects of M100907, SDZ PSD 958 and raclopride

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901195-7

Non-NMDA excitatory amino acid receptors in the ventral tegmental area mediate systemic dizocilpine (MK-801) induced hyperlocomotion and dopamine release in the nucleus accumbens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901195-7

Blockade of phencyclidine-induced hyperlocomotion by clozapine and MDL 100,907 in rats reflects antagonism of 5-HT2A receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901195-7

Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901195-7

Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901195-7

Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901195-7

Phencyclidine- and Dizocilpine-Induced Hyperlocomotion Are Differentially Mediated

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901195-7

Excitotoxic amino acids and neuropsychiatric disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901195-7

Glutamate receptor dysfunction and schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901195-7

Effects of continuous D-amphetamine and phencyclidine administration on social behaviour, stereotyped behaviour, and locomotor activity in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901195-7

The effects of haloperidol and clozapine on PCP- and amphetamine-induced suppression of social behavior in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901195-7

Crucial role of the accumbens nucleus in the neurotransmitter interactions regulating motor control in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901195-7

Dysfunctional brain dopamine systems induced by psychotomimetic NMDA-receptor antagonists and the effects of antipsychotic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901195-7

Brain microdialysis of GABA and glutamate: what does it signify?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901195-7

M100907, a serotonin 5-HT2A receptor antagonist and putative antipsychotic, blocks dizocilpine-induced prepulse inhibition deficits in Sprague-Dawley and Wistar rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901195-7

NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901195-7

M100907 and clozapine, but not haloperidol or raclopride, prevent phencyclidine-induced blockade of NMDA responses in pyramidal neurons of the rat medial prefrontal cortical slice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901195-7

Involvement of serotonin 2A receptors in phencyclidine-induced disruption of prepulse inhibition of the acoustic startle in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901195-7

Schizophrenia and glutamatergic transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901195-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-3223(01)01195-7

1 reference

27 November 2017

1 reference

PubMed ID

11720693